According to IMARC Group’s latest report, titled “ Extracorporeal Membrane Oxygenation Machine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global extracorporeal membrane oxygenation machine market exhibited moderate growth during 2015-2020. Extracorporeal membrane oxygenation (ECMO) machine is a life support equipment that oxygenates red blood cells (RBCs) of patients suffering from prolonged cardiac and respiratory problems. It is extensively used when the heart and lungs cannot provide an adequate amount of gas exchange or perfusion that sustains life. The machine pumps out the blood to remove the carbon dioxide and sends back rewarmed, oxygen-filled blood back into the body. ECMO machine is usually applied in critical care situations to allow blood to bypass the heart and lungs, enabling the organs to rest and heal.Request for a PDF sample of this report: https://www.imarcgroup.com/extracorporeal-membrane-oxygenation-machine-market/requestsample
The global extracorporeal membrane oxygenation machine market is primarily driven by the increasing prevalence of respiratory infections and cardiovascular diseases and strokes. The rising awareness among individuals about the benefits of ECMO machines has also escalated its demand globally. Besides this, these machines are increasingly being used for patients who are more susceptible to chronic medical ailments like coronavirus disease (COVID-19) and acute respiratory distress syndrome (ARDS). Furthermore, the rising number of tobacco smokers, the growing geriatric population and the newborns suffering from respiratory diseases due to congenital disabilities and trauma are some of the other factors that are significantly influencing the market growth. Looking forward, IMARC Group expects the global extracorporeal membrane oxygenation machine market to grow at a CAGR of around 5% during the forecast period (2021-2026).
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Competitive Landscape with Key Players:
Abbott Laboratories
ALung Technologies Inc.
Braile Biomedical
Eurosets, LivaNova PLC
Medtronic
MicroPort Scientific Corporation
Nipro Medical Corporation
Origen Biomedical, Inc.
Terumo Corporation
Xenios AG.
Market Segmentation:
Breakup by Component:
Pumps
Oxygenator
Controllers
Cannula
Accessories
Breakup by Modality:
Veno-Arterial
Veno-Venous
Arterio-Venous
Breakup by Patient Type:
Neonates
Pediatric
Adult
Breakup by Application:
Respiratory
Cardiac
ECPR
Breakup by Region:
North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://bit.ly/3ElUDCR
We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF.